Etiology of Fungemia in Neonates: Four Decades of Case Reports


Objectives: To compare groups of etiologic agents for neonatal fungemia based on previously published case reports with regard to case outcomes. Methods: Secondary analysis of data from case reports published in scientific literature indexed in Medline, Scopus and LILACS databases, and starting from the year, full texts were registered until the year 2010. Results: Thirty-four species of fungi were isolated in 252 cases reported over a 40-year period. The distribution of fungal groups according to the development level of a case’s region of origin was very uneven (p < 0.001), with a predominance of C. albicans and other fungi (Aspergillus sp.) in more developed countries. However, 73% of the chi-squared distribution corresponded to differences observed in the frequency of Candida sp. and non-albicans Candida. While the frequency of candidemia by C. albicans was progressively declining in the period from 1966 to 2010, reports of non-albicans candidemia and other non-Candida fungi became significantly (p < 0.00001) more frequent over the course of the period studied. As for the outcome of death, it was statistically more frequent (p < 0.02) in cases where non-albicans Candida or non-Candida fungi were isolated. Conclusion: fungi of the genera Candida and Aspergillus were the etiologic agents most frequently identified in published cases of neonatal fungemia; the outcome of death was more often related to cases where non-albicans Candida or non-Candida fungi were isolated.

Share and Cite:

Amaral-Lopes, S. and Tavares-Neto, J. (2014) Etiology of Fungemia in Neonates: Four Decades of Case Reports. Open Journal of Medical Microbiology, 4, 97-105. doi: 10.4236/ojmm.2014.42011.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Clark, R., Powers, R., Withe, R., Bloom, B., Sanchez, P. and Benjamin Jr., D.K. (2004) Nosocomial Infection in the NICU: A Medical Complication or Unavoidable Problem? Journal of Perinatology, 24, 382-388.
[2] Benjamin Jr., D.K., Stoll, B.J., Fanaroff, A.A., McDonald, S.A., Oh, W., Higgins, R.D., et al. (2006) Neonatal Candidiasis among Extremely Low Birth Weight Infants: Risk Factors, Mortality Rates, and Neurodevelopmental Outcomes at 18 to 22 Months. Pediatrics, 117, 84-92.
[3] Blyth, C.C., Chen, S.C., Slavin, M.A., Serena, C., Nguyen, Q., Marriott, D., et al. (2009) Not Just Little Adults: Candidemia Epidemiology, Molecular Characterization, and Antifungal Susceptibility in Neonatal and Pediatric Patients. Pediatrics, 123, 1360-1368.
[4] Stoll, B.J., Hansen, N.I., Bell, E.F., Shankaran, S., Laptook, A.R., Walsh, M.C., et al. (2010) Neonatal Outcomes of Extremely Preterm Infants from the NICHD Neonatal Research Network. Pediatrics, 126, 443-456.
[5] Clerihew, L., Lamagni, T.L., Brocklehurst, P. and McGuire, W. (2006) Invasive Fungal Infection in Very Low Birthweight Infants: National Prospective Surveillance Study. Archives of Disease in Childhood. Fetal and Neonatal Edition, 91, F188-F192.
[6] Wang, M., Tran, Tu., Tran, V., Padilla, L. and Le Jennifer (2011) Case-Control Study of Risk Factors and Outcomes Associated with Neonatal Candidiasis. The Journal of Neonatal-Perinatal Medicine, 4, 39-43.
[7] Rodriguez, D., Almirante, B., Cuenca-Estrella, M., Rodriguez-Tudela, J.L., Mensa, J., Ayats, J., et al. (2010) Predictors of Candidaemia Caused by Candida Species Non-Albicans: Result of a Population-Based Surveillance in Barcelona, Spain. Clinical Microbiology and Infection, 16, 1666-1682.
[8] De Pauw, B., Walsh, T.J., Donnelly, J.P., Stevens, D.A., Edwards, J.E., Calandra, T., et al. (2008) Revised Definitions of Invasive Fungal Disease from European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Disease Mycoses Study Group (EORTC/ MSG) Consensus Group. Clinical Infectious Diseases, 46, 1813-1821.
[9] Walsh, T.J., Groll, A., Hiemenz, J., Fleming, R., Roilidies, E. and Anaissie, E. (2004) Infections Due to Emerging and Uncommon Medically Important Fungal Pathogens. Clinical Microbiology and Infection, 10, 48-66.
[10] Roilides, E. and Walsh, T.J. (2010) Invasive Fungal Infection in Pediatric Patients. Clinical Microbiology and Infection, 16, 1319-1320.
[11] Neu, N., Malik, M., Lunding, A., Whittier, S., Alba, L., Kubin, C. and Saiman, L. (2009) Epidemiology of Candidemia at a Children’s Hospital, 2002 to 2006. The Pediatric Infectious Disease Journal, 28, 806-809.
[12] Figueiredo, G.C. and Tavares-Neto, J. (2001) Structuring a Database for Secondary Analysis of Information in Reports or Case Series. Revista Brasileira de Ortopedia, 36, 407-411.
[13] Hulley, S., Cummings, S.R., Browner, W.S., Grady, D.G. and Newman, T.B. (2008) Outlining Clinical Research, an Epidemiological Approach. 3th Edition, Guilford Press, New York.
[14] Amaral, P.M. and Tavares-Neto, J. (2010) Construction and Proposal of Evaluation Tools: A Biological Material for Occupational Health Personnel Exposure. Revista Brasileira de Saúde Ocupacional, 35, 131-147.
[15] Amaral-Lopes, S. (2011) Fungemia in the Neonatal Period: A Secondary Data Analysis. Ph.D. Dissertation, Federal University of Bahia, Salvador.
[16] Figueiredo, G.C., Figueiredo, E.C.Q., Medeiros, A.K., Costa, F.A., Maia Junior, J.R. and Tavares-Neto, J. (2006) Fungal Osteomyelitis: A Secondary Analysis of Data. Revista Brasileira de Ortopedia, 41, 200-210.
[17] Figueiredo, G.C., Figueiredo, E.Q.C. and Tavares-Neto, J. (2001) Clinical and Therapeutic Aspects of Fungal Vertebral Osteomyelitis―Secondary Analysis of Data. Brazilian Journal of Rheumatology, 47, 34-44.
[18] Kirk, P.M. (2000) Species Fungorum (version 9.0, Sep 2010). In: Bisby, F.A., Roskov, Y.R., Orrell, T.M., Nicolson, D., Paglinawan, L.E., Bailly, N., Kirk, P.M., Bourgoin, T., Baillargeon, G. and Ouvrard, D., Eds., Species 2000 & ITIS Catalogue of Life, 26th July 2011.
[19] Gniadek, A., Macura, A.B., Twaruzek, M. and Grajewski, J. (2010) Cytotoxicity of Aspergillus Strains Isolated from the Neonatal Intensive Care Unit Environment. Advances in Medical Sciences, 55, 242-249.
[20] Sarvikivi, E., Lyytikainen, O., Soll, D.R., Pujol, C., Pfaller, M.A., Richardson, M., Koukila-Kahkola, P., Luukkainen, P. and Saxén, H. (2005) Emergence of Fluconazole Resistance in a Candida Parapsilosis Strain That Caused Infections in the Neonatal Intensive Care Unit. Journal of Clinical Microbiology, 43, 2729-2735.
[21] Manzoni, P., Jacqz-Aigrain, E., Rizzollo, S., Franco, C., Stronati, M., Mostert, M. and Farina, D. (2011) Antifungal Prophylaxis in Neonates. Early Human Development, 87, 59-60.
[22] Yildiran, A., Belet, N., Gunaydin, M. and Kucukoduk, S. (2010) Comparison of Antifungal Susceptibilities in Candidemic Newborns According to Their Body Weights. Balkan Medical Journal, 27, 234-237.
[23] Pappas, P.G., Kauffman, C.A., Andes, D., Benjamin Jr., D.K., Calandra, T.F., Edwards Jr., J.E., et al. (2009) Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases, 48, 503-535.
[24] Brecht, M. and Clerihew McGuire, L. (2009) Prevention and Treatment of Invasive Fungal Infection in Very Low Birthweight infants. Archives of Disease in Childhood. Fetal and Neonatal Edition, 94, 65-69.
[25] Saiman, L., Ludington, E., Pfaller, M., Rangel-Frausto, S., Wiblin, R.T., Dawson, J., Blumberg, H.M., Patterson, J.E., Rinaldi, M., Edwards, J.E., Wenzel, R.P. and Jarvis, W. (2000) Risk Factors for Candidemia in Neonatal Intensive Care Unit Patients. The Pediatric Infectious Disease Journal, 19, 319-324.
[26] Rodriguez, D., Almirante, B., Park, B.J., Cuenca-Estrella, M., Planes, A.M., Sanchez, F., Gene, A., Xercavins, M., Fontanals, D., Rodriguez-Tudela, J.L., Warnock, D.W. and Pahissa, A. (2006) Candidemia in Neonatal Intensive Care Units Barcelona, Spain. The Pediatric Infectious Disease Journal, 25, 224-229.
[27] Moran, G.P., Coleman, D.C. and Sullivan, D.J. (2011) Comparative Genomics and the Evolution of Pathogenicity in Human Pathogenic Fungi. Eukaryotic Cell, 10, 34-42.
[28] Fernandez, J., Erstad, B.L., Petty, W. and Nix, D.E. (2009) Time to Positive Culture and Identification for Candida Bloodstream Infections. Diagnostic Microbiology and Infectious Disease, 64, 402-407.
[29] Garey, K.W., Rege, M., Pai, M.P., Mingo, D.E., Suda, K.J., Turpin, R.S. and Bearden, D.T. (2006) Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A multi-Institutional Study. Clinical Infectious Diseases, 43, 24-31.
[30] Cho, J., Holditch-Davis, D. and Miles, M.S. (2010) Effects of Gender on the Health and Development of Medically At-Risk Infants. Journal of Obstetric, Gynecologic, & Neonatal Nursing, 39, 536-549.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.